From: The biochemical aftermath of anti-amyloid immunotherapy
Mr Observed | Mr Calculated | Peptide Sequence |
---|---|---|
3371.2 | 3373.0 | 17-49 (2f) |
3442.2 | 3444.1 | 17-50 (f) |
3486.1 | 3488.1 | 17-50 (ox/2f) |
4514.5 | 4514.1 | 1-42 |
4925.5 | 4924.7 | 2-47 |
4940.7 | 4942.6 | 1-46 (ox) |
5371.4 | 5670.8 | 11-62 |
6178.3 | 6177.2 | 6-61 (3f) |
6723.3 | 6724.9 | 11-73 (ox) |
7178.2 | 7180.3 | 4-68 (3ox) |
8202.0 | 8204.1 | 3pE-40 + 4-40 (4ox) |
8411.7 | 8412.3 | 3pE-40 + 2-40 (ox/2f) |
8450.4 | 8445.4 | dimer 2-40 (ox) |
8565.4 | 8563.9 | 5-82 |
9265.5 | 9262.4 | dimer 1-43 (2ox) |
9273.0 | 9273.7 | 17-99 (4ox) |
9624.0 | 9623.1 | 11-96 (ox) |